NFMRI - Key Persons
Her early career was with Westpac Financial Markets in money markets and foreign exchange. In 2002, she joined Mr Christopher Abbott AM (founding partner of institutional fund manager Maple-Brown Abbott), in his private family office Asia Union Investments Pty Ltd, making significant investments into private and public Australian biotechs, lifescience funds and VCs. In 2015, Alison joined Melbourne based lifescience fund Bioscience Managers to establish two new funds: a VCLP and BioScience Managers Translation Fund I, as part of the Australian Government's Biomedical Translation Fund initiative. In 2018, Alison left Bioscience Managers to co-found Sydney-based digital health company Evidentli Pty Ltd, an A.I. company that automates the analysis of ‘real world data' designed to be used by clinicians and medical researchers. In 2019, she joined the research advisory committee of NFMRI assessing new technologies emerging across Australian universities and medical institutes. In October 2020 she joined their board. Also in 2020 Alison joined Australian CAR T company Chimeric Therapeutics Ltd and radiotherapeutics company Radiopharm Theranostics Ltd as Project Manager. Both companies listed on the ASX in 2021 (ASX:CHM and ASX:RAD). show less
Prof Joshua was Head of Clinical and Laboratory Haematology at Sydney Cancer Centre, Head of Sydney Local Health District in Hematology, the Alan Ng Professor in Medicine at University of Sydney, and the Director of the Institute of Hematology, Royal Prince Alfred Hospital, until his retirement in 2014.
Chief Executive Officer - Noel was appointed as the Chief Executive Officer of the Foundation in April 2013.
Rob joined as a Director of the National Foundation for Medical Research and Innovation in 2017 and was appointed as Chairman in 2018.
Job Titles:
- Member of the Board of Directors
Kevin Hellestrand has been a member of the Board of Directors in since 2001.
Bookkeeper - Linda joined NFMRI in October 2022, having previously run her own Bookkeeping/BAS Agency business working with various clients in sectors ranging from trade, retail, manufacturing, health and hospitality.
In 2004, Tony was a Founding Partner of McGrathNicol. Prior to this, Tony was the head of the Sydney Corporate Recovery division of KPMG. He has over 30 years of restructuring and insolvency experience. Tony has acted as a Liquidator of the HIH Insurance Group, which has been one of the largest failures in Australian corporate history. Other key engagements have included acting as Liquidator of the Pan Pharmaceuticals Group and the Voluntary Administration of the Henry Walker Eltin Group, All, Acting Trustee of Trio and Receiver of Banksia. Tony is a Non-Executive Director of Servcorp Ltd., is a Commissioner of the Australian Rugby League and is also a Director of a number of other not-for-profit organisations. show less
Mr Harkness was a partner of KPMG for 24 years and National Executive Chairman for five years.
Job Titles:
- Communications and Engagement Coordinator
Grants, Communications and Engagement Coordinator - Nancy joined NFMRI in March 2014 following her recent role at the Myer Family Company, where she worked directly with ultra high-net-worth families and clients on the administration of their strategic giving programs.
Job Titles:
- Foundation As a Company Secretary
Alison Choy Flannigan joined the Foundation as a Company Secretary in 2014.
Job Titles:
- Professor Ian Smith Joined NFMRI 's Board of Directors in 2017
Professor Ian Smith joined NFMRI's Board of Directors in 2017.
Tony McGrath, has been Honorary Secretary of the Foundation since 1997.